Is Medifast Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: MED) stock is to Hold MED stock.
Out of 1 analyst, 0 (0%) are recommending MED as a Strong Buy, 0 (0%) are recommending MED as a Buy, 1 (100%) are recommending MED as a Hold, 0 (0%) are recommending MED as a Sell, and 0 (0%) are recommending MED as a Strong Sell.
What is MED's forecast return on equity (ROE) for 2023-2025?
(NYSE: MED) forecast ROE is N/A, which is considered weak.
What is MED's Price Target?
According to 1 Wall Street analyst that have issued a 1 year MED price target, the average MED price target is $80.00, with the highest MED stock price forecast at $80.00 and the lowest MED stock price forecast at $80.00.
The Wall Street analyst predicted that Medifast's share price could reach $80.00 by Aug 8, 2024. The average Medifast stock price prediction forecasts a potential upside of 3.2% from the current MED share price of $77.52.
What is MED's forecast return on assets (ROA) for 2023-2025?
(NYSE: MED) forecast ROA is N/A, which is lower than the forecast US Personal Services industry average of 5.98%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.